Category

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19 – 26 June 2026, and includes updates on Ebola, West Nile Virus infections, Crimean-Congo haemorrhagic fever, Influenza A(H9N2), cholera, mpox, dengue, expert deployment, travel-associated chikungunya virus disease in EU/EEA countries, and an overview of respiratory virus epidemiology in the EU/EEA

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 May 2026, and includes updates on SARS-CoV-2 variant classification, Ebola, Middle East respiratory syndrome (MERS), mpox, West Nile virus, Salmonella, Dermatophilus congolensis and malaria.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 May 2026, and includes updates on Ebola, hantavirus, cholera, West Nile virus, and an overview of respiratory virus epidemiology in the EU/EEA.

The European Centre for Disease Prevention and Control (ECDC) hosted the annual meeting of the European Respiratory Viruses Network (ERVI-Net) in Vienna, Austria, on 20–22 May 2026, which brought together nearly 80 representatives from EU/EEA and accession countries.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-22 May 2026, and includes updates on hantavirus, chikungunya, Ebola disease outbreak, avian influenza, measles, and an overview of respiratory virus epidemiology in the EU/EEA.

Respiratory virus activity remains low overall across the EU/EEA: RSV: activity has returned to baseline inter-seasonal levels. Influenza: activity remains at baseline inter-seasonal levels. SARS-CoV-2: activity remains at very low levels overall.

This handbook provides an updated overview of commonly used laboratory protocols for the characterisation of SARS-CoV-2, provided by the AURORAE consortium.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 May 2026, and includes updates on hantavirus, mpox, Middle East respiratory syndrome coronavirus (MERS-CoV), Salmonella Stanley, and an overview of respiratory virus epidemiology in the EU/EEA.

Most respiratory virus activity remains low overall across the EU/EEA. RSV: low activity; still the main contributor to severe disease, with the seasonal peak largely passed. Influenza: activity has returned to inter-seasonal levels. SARS-CoV-2: Very low activity overall, despite early signs of sustained transmission in primary care.

Most respiratory virus activity remains low overall across the EU/EEA. RSV: low activity and returning to baseline levels, with the seasonal peak already passed in most countries. Influenza: activity has returned to inter-seasonal levels. COVID 19: Very low activity.